Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 studyMax S. Topp, Hagop M. Kantarjian, Susan O’Brien et al.|The Lancet Oncology|2014Cited by 1.3k
Highly efficient collection and manufacture of autologous HSC gene therapy cell product for patients with sickle cell disease using a lentiviral vector containing a shmir targeting BCL11aJohn Manis, David A. Williams, David G. Justus et al.|Blood|2025Cited by 1